Gossamer Bio Inc (NASDAQ: GOSS) kicked off on Friday, up 5.94% from the previous trading day, before settling in for the closing price of $1.01. Over the past 52 weeks, GOSS has traded in a range of $0.45-$1.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 77.55%. With a float of $186.86 million, this company’s outstanding shares have now reached $225.41 million.
Considering the fact that the conglomerate employs 135 people, you should pay attention to its efficiency factor.
Gossamer Bio Inc (GOSS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Gossamer Bio Inc is 17.40%, while institutional ownership is 66.56%. The most recent insider transaction that took place on Jun 24 ’24, was worth 1,260. In this transaction Chief Medical Officer of this company sold 1,908 shares at a rate of $0.66, taking the stock ownership to the 196,891 shares. Before that another transaction happened on Jun 21 ’24, when Company’s President & CEO bought 372,000 for $0.67, making the entire transaction worth $250,282. This insider now owns 5,408,073 shares in total.
Gossamer Bio Inc (GOSS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 77.55% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 5.20% during the next five years compared to 11.99% growth over the previous five years of trading.
Gossamer Bio Inc (NASDAQ: GOSS) Trading Performance Indicators
Take a look at Gossamer Bio Inc’s (GOSS) current performance indicators. Last quarter, stock had a quick ratio of 8.21. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.53.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.40, a number that is poised to hit -0.15 in the next quarter and is forecasted to reach -0.70 in one year’s time.
Technical Analysis of Gossamer Bio Inc (GOSS)
Compared to the last year’s volume of 1.54 million, its volume of 1.34 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 64.73%. Additionally, its Average True Range was 0.08.
During the past 100 days, Gossamer Bio Inc’s (GOSS) raw stochastic average was set at 65.54%, which indicates a significant decrease from 83.26% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.02% in the past 14 days, which was lower than the 86.95% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9182, while its 200-day Moving Average is $0.9354. Nevertheless, the first resistance level for the watch stands at $1.1067 in the near term. At $1.1433, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.1967. If the price goes on to break the first support level at $1.0167, it is likely to go to the next support level at $0.9633. Should the price break the second support level, the third support level stands at $0.9267.
Gossamer Bio Inc (NASDAQ: GOSS) Key Stats
The company with the Market Capitalisation of 242.07 million has total of 226,219K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -179,820 K annual income. Company’s last quarter sales were recorded 95,840 K and last quarter income was 49,230 K.
